In the liver microsome cyanide (CN)-trapping assays, piperazinecontaining compounds formed significant N-methyl piperazine CN adducts. Two pathways for the N-methyl piperazine CN adduct formation were proposed: 1) The a-carbon in the N-methyl piperazine is oxidized to form a reactive iminium ion that can react with cyanide ion; 2) N-dealkylation occurs followed by condensation with formaldehyde and dehydration to produce Nmethylenepiperazine iminium ion, which then reacts with cyanide ion to form the N-methyl CN adduct. The CN adduct from the second pathway was believed to be an artifact or metabonate. In the present study, a group of 49-N-alkyl piperazines and 49-N- 
Introduction
Drug-induced toxicity is one of the major reasons for withdrawal of marketed drugs (Kaplowitz, 2005) . Investigation of the underlying mechanisms for adverse drug reactions (ADRs) is among the major efforts of pharmaceutical companies, along with managing risks associated with acute toxicities (Smith and Obach, 2009) . Drugs that are metabolized to generate electrophilic reactive intermediates, which can form covalent adducts with macromolecules, carry an increased risk of ADRs or idiosyncratic toxicity (Walgren et al., 2005; Waring and Anderson, 2005; Ulrich, 2007) and drug-drug interactions caused by mechanism-based inactivation (MBI) of cytochrome P450 enzymes (Orr et al., 2012) . Glutathione, potassium cyanide (KCN), methoxyamine, and semicarbazide have become widely used as trapping agents to evaluate the metabolic activation potential of drug molecules (Evans et al., 2004; Kalgutkar and Soglia, 2005; Kumar et al., 2008) . Cyanide was first introduced as an agent in the 1950s to study hard electrophilic molecules such as N-substituted nicotinamide compounds (Colowick et al., 1951) . Alicyclic amines, such as nicotine and prolintane, which form hard electrophilic iminium ions, are highly reactive with cyanide, suggesting their potential to react with macromolecules (Murphy, 1973) . Other alicyclic amines, such as nefazodone, indinavir, and prochlorperazine, have also been shown to form iminium ions that react with cyanide (Gorrod and Aislaitner, 1994) .
In CN-trapping assays performed on secondary alicyclic amines, such as the nefazodone N-dealkylation product, significant CN adduct was found with an addition of 14 Da in the molecule (Argoti et al., 2005; Bauman et al., 2008) . In our CN-trapping screening on Ndealkylated alicyclic compounds, significant CN adducts with an additional 14 Da were also observed and confirmed as the addition of a methylene group (unpublished data). It has been suggested that this type of N-methylated CN adduct from the secondary alicyclic amines was an experimental artifact, or "metabonate," from an in vitro microsomal incubation system (Gorrod and Sai, 1997; Li et al., 2006; Rousu and Tolonen, 2011; Barbara et al., 2012) . In the case of N-methyl piperazines, there are two possible pathways for the formation of Nmethyl piperazine CN adducts (Fig. 1) . In pathway 1, the iminium ion is formed via a-carbon oxidation, which could have potential toxicological implications (Sayre et al., 1997) and cause MBI of the cytochrome P450 enzymes (Orr et al., 2012) . In pathway 2, Ndealkylation results in the formation of a secondary alicyclic amine, which can react with formaldehyde and eventually lead to the formation of an iminium ion. The CN adduct from pathway 2 has been considered the artifact from the in vitro system and irrelevant to in vivo (Gorrod and Sai, 1997; Rousu and Tolonen, 2011; Barbara et al., 2012) . In the study reported here, we have evaluated the mechanism of CN adduct formation in several piperazine-containing compounds ( Fig. 2 ) with secondary and tertiary alicyclic amines. Piperazine compounds with [ 13 C]-labeled 49-N-methyl group were used to quantify the contribution of each pathway to the formation of 49-N-methyl piperazine CN adduct in liver microsomal incubations. Furthermore, by identifying the one-carbon sources for the formation of the 49-N-methyl piperazine iminium ion, we have demonstrated the relevance of pathway 2 of CN adduct formation to the in vivo system and, thereby, to the potential ADR and MBI liabilities.
Materials and Methods
The 49-N-alkyl piperazine compounds tetrahydronapthalenes (III, IV), chromans (VII and X-XIV), and the 49-N-desmethyl piperazine compounds (I, VI, and IX) were synthesized by AstraZeneca (Wilmington, DE) Cyanomethyl piperazine analog (II) was prepared by alkylation of the des-methyl precursor with bromoacetonitrile and potassium carbonate in dimethylsulfoxide. The [ 13 C]-labeled adducts (V and VIII) were prepared by the reductive amination of the des-methyl precursor with [ 13 C]paraformaldehyde, sodium cyanoborohydride, and triethylamine in methanol. The structures were confirmed by nuclear magnetic resonance, and the purity was determined by LC/ultraviolet. The purity of the [ 13 C]-labeled compounds was greater than 98%.
Microsomal Incubation
Formation of the CN adduct was measured in HLM and RLM incubations. Unless specified, the 1-ml incubation media contained 10 mM test compound, dmd.aspetjournals.org 1 mg/ml of microsomal protein, 5 mM magnesium chloride, 5 mM KCN, and 1 mM NADPH in 100 mM phosphate buffer, pH 7.4. After preincubation at 37°C for 3 minutes, the reaction was initiated by the addition of the test compound. Equal volumes of cold acetonitrile were added to terminate the reaction at 30 minutes. After removal of denatured protein by centrifugation, the supernatant was analyzed by LC coupled with mass spectrometry.
To investigate the carbon source for N-methylated piperazine CN-adduct, 10 mM 49-N-desmethyl piperazine compound (I or IX) was incubated with HLM in a phosphate buffer (pH 7.4) in the presence of KCN as described, with either 5 mM [
13 C]-labeled potassium carbonate, 1% of methanol (v/v), or 1% of formaldehyde (v/v) included in the incubation. The reaction was initiated by the addition of NADPH. The control incubations that contained all components except KCN were performed. To determine the contribution of enzymes and NADPH to the formation of CN adducts, compound I or IX was also incubated in a solution containing all components except liver microsome or NADPH. In a separate study, compound I was incubated in HLM in the presence of 5 mM 
LC/MS Analysis
The CN adducts formed in microsomal incubation were analyzed by ACQUITY Ultra Performance Liquid Chromatography (UPLC) system (Waters, Milford, MA) coupled with API 4000 QTRAP (Applied Biosystems, Foster City, CA) or LTQ Orbitrap mass spectrometer (Thermo Scientific, San Jose, CA). A 2.1 Â 100-mm BEH C18 column with 1.7-mm particle size (Waters) was used for the UPLC separation. Eluting solvents consisted of 0.1% formic acid and 5% acetonitrile in LC/MS grade water (A) and 0.1% formic acid in acetonitrile (B). The elution gradient, at flow rate of 0.2 ml/min, started with 0% B, linearly increased to 20% B in 4 minutes, and then linearly increased to 80% B in 3 minutes, to 95%B in another 2 minutes, and held at 95% B for additional 2 minutes. The column was then equilibrated by washing with 100% A for 3 minutes.
API 4000 QTRAP Analysis. The UPLC eluants were ionized under positive electrospray ionization mode with curtain gas set at 25, collision gas at 10, ion spray voltage at 4500 V, temperature at 450°C, ion source gas 1 at 50, ion source gas 2 at 50, declustering potential at 45 V, enhanced potential at 10 V, and collision cell exit potential at 15 V. Information-dependent acquisition was applied to trigger the enhanced product ionization scan to obtain tandem mass spectrometry (MS/MS) fragmentation for ions exceeding 10,000 counts per second from the enhanced MS scan or for ions exceeding 1000 counts per second from the scan for neutral loss (NL) of 27 (NL-27) atomic mass units (amu) with a dwell time of 30 milliseconds. The collision energy (CE) for the NL and enhanced product ionization scans was set at 25 and 45 V, respectively.
LTQ Orbitrap Analysis. The CN adduct structures were also analyzed by Orbitrap mass spectrometer under positive electrospray ionization mode with source voltage at 4 kV, capillary temperature at 275°C, and the sheath gas flow rates at 60 arbitrary units. The Orbitrap Fourier transform mass spectrometer resolution was set at 15,000 with a scan range at 50-600 m/z. Data-dependent MS 2 and MS 3 fragmentation were obtained in the linear ion trap where the normalized CE was set at 35 with 0.23 activation Q and 30-millisecond activation time.
Data Processing
Accurate mass data acquisition, process, and theoretical isotope spectra simulation were conducted with Xcalibur 2.1 (Thermo Scientific). Unit resolution mass data and NL-27 chromatograms were generated with Analyst version 1.4.2 (AB Sciex, Foster City, CA). The natural abundance ratio of 
Results

CN Adduct Formation and Structure Confirmation
Tetrahydronapthalene Compounds. When 49-N-desmethyl piperazine (I) was incubated in HLM or RLM with trapping agent KCN, a major CN adduct peak at retention time of 8.7 minutes was detected in LC/MS analysis monitoring NL-27 ions (Fig. 3 ). This CN adduct had a molecular ion at m/z 460.2716 (C 27 H 34 O 2 N 5 , Δ = 2.0 ppm), which is consistent with the addition of a methyl and a CN group. This CN adduct peak matched the synthetic standard (II) peak in both retention time and MS characteristics (Fig. 4) . When 49-N-methyl piperazine (IV) was incubated in HLM or RLM with KCN, three 49-Nmethyl piperazine CN adduct peaks were detected in the NL-27 ion chromatograms, with the parent molecular ion at m/z 460 (Fig. 5 ). Structural assignments of these three CN adducts generated from IV were based on the MS/MS fragmentation patterns and the chromatographic fragments of these CN adducts (Fig. 6 ). When the CN group was in the piperazine moiety, the intact benzoic-morpholine ion fragment (m/z 190) was observed (Fig. 6 , A, C, and D). Peak 1 generated a fragment at m/z 188, consistent with the benzoic-morpholine fragment after an NL of HCN group from the morpholine ring (Fig. 6B) ; therefore, the CN adduct group was assigned to morpholine. The retention time of peak 3 ( Fig. 5 ) and its fragmentation patterns (Fig. 6D) matched those of the synthetic standard II (Figs. 4 and 6A, respectively), confirming that in peak 3, the CN adduct was in the 49-N-methyl group. Peak 2 generated a benzoic-morpholine fragment at m/z 190 (Fig. 6C ), but the retention time did not match standard II, indicating that its CN adduct is unlikely at the 4'-N-methyl group; therefore, the only other place left in piperazine to assign the CN adduct would be at the 29 or 39-position.
When 49-N-[
13 C]methyl piperazine (V) was incubated with (either rat or human) liver microsomes, the same peaks 1, 2, and 3 were formed (Fig. 7) . Since the CN adduct in peak 1 was in the morpholine ring, the 49-N-[
13 C]methyl piperazine was intact in the molecule, and there was no loss of [
13 C]-label in the peak. In peak 2, [ 13 C]methyl group was also retained demonstrating that the methyl piperazine CN adducts in peak 2 was not preceded by 49-N-demethylation; rather, it was through a-oxidation at 29 or 39 position (pathway 1). However, in peak 3, a significant amount of 49-N-[ 13 C]methyl group was replaced by natural 12 C-methyl group (Fig. 7) , indicating that most methyl piperazine CN adducts in peak 3 were formed after the 49-N-demethylation (pathway 2) as illustrated in Fig. 8 .
Chroman Compounds. As in the tetrahydronapthalene compounds under the same incubation conditions, 49-N-desmethyl piperazine (VI) also generated a major 49-N-methyl piperazine CN-adduct (Fig. 9) . Accurate mass analysis of this CN adduct showed a molecular ion at m/z 480.2424 (C 26 H 31 O 3 N 5 F, Δ = 2.7 ppm), consistent with the Artifacts in N-Methyl Piperazine Cyanide Adduct Formation addition of methyl and CN group to compound VI. Three major and one minor methyl piperazine CN-adduct peaks were observed in microsomal incubations of compound VII with KCN (Fig. 10) , and peak 3 (RT 8.8 minutes) matched the 49-N-methyl piperazine CN-adduct peak from VI in Fig. 9 . The fragmentation pattern of the parent compound VII revealed that the fragment ion at m/z 277 was consistent with the chroman-8-(49-N-methylpiperazine)-2-carbonyl moiety (Fig. 11A) , which could be used as signature fragment ion to locate the sites of CN adducts. Fragmentation of 49-N-methyl CN-adduct ion at m/z 480 from peaks 1, 2, and 3 (Fig. 10 ) generated a product ion at m/z 453 as the result of an NL of 27 (HCN). Further fragmentation of the ion at m/z 453 generated a product ion at m/z 275, which is consistent with the chroman-8-(49-N-methylpiperazine)-2-carbonyl moiety upon an NL of HCN (Fig. 11, B-D) , suggesting that the CN adduct was in the piperazine moiety for peaks 1-3. Because of its low quantity, the minor methyl piperazine CN adduct peak shown in Fig. 10 did not trigger fragmentation and was not evaluated further. The MS/MS fragmentation pattern of the 49-N-methyl piperazine CN-adduct (major peak in Fig. 9 ) of N-desmethyl piperazine (VI) was similar to those of the 49-N-methyl piperazine CN-adducts (peaks 1--3) generated from VII (unpublished data). Similar results were observed for compounds IX and X (unpublished data). When 49-N-[ 13 C]methyl piperazine compound (VIII) was incubated in liver microsomes with KCN, a significant [ 13 C]methyl group was replaced by natural methyl group in CN adduct peak 3, whereas in peaks 1 and 2, the 49-N-[ 13 C]methyl group was retained in the CN adducts (Fig. 12) , confirming that the CN adduct in peak 3 was associated with 49-N in the piperazine and that most CN adduct in peak 3 was formed via pathway 2 as illustrated in Fig. 13 . 12 C]methyl group in the CN adduct peak 3, indicating a significant contribution of pathway 2 (Figs. 7 and 12) . In HLM incubations, pathway 2 represented 75-80% of the 49-Nmethyl CN adduct formation (Table 1) . In RLM incubations with KCN, it represented 60-70%. The percent of contribution by pathway 2 appeared to correlate with the extent of 49-N-dealkylation of the piperazines. The peak areas of 49-N-dealkylation products from compounds X-XIV were much smaller than those from compounds III, IV, and VII, consistent with significantly lower levels of 49-Nmethyl piperazine CN adduct formation from compounds X-XIV (Tables 2 and 3 ). After normalizing the peak areas of 49-Ndealkylations products and 49-N-methyl piperazine CN adducts against parent peak areas in Tables 2 and 3 (Fig. 17) . Formaldehyde and methanol appeared to be more effective as one-carbon donors than potassium carbonate. After 30 minutes of HLM incubation in the presence of KCN and potassium carbonate as the one-carbon donor, only minor 49-N-methyl piperazine CN adduct peaks were formed. However, when formaldehyde or methanol was used, significant levels of the parent compounds (I or IX) were converted to 49-N-methyl piperazine CN adduct. Under current CN-trapping conditions with excess of one-carbon donor in the microsomal incubation, formaldehyde and methanol generated similar amounts of 49-N-methyl piperazine CN adduct as measured by peak area counts (Fig. 17) .
Contribution of
When (Fig. 18) . When incubated with the same [
13 C]-labeled one-carbon donors in the presence of NADPH and KCN, but in the absence of HLM, similar results were observed (Fig. 19) . When compound I was incubated in HLMs in the presence of [
13 C]-labeled potassium carbonate, KCN and the aldehyde trapping agent semicarbanzide, CN adduction formation was significantly reduced (Fig. 20) .
Discussion
In this study, several approaches were applied to investigate the mechanisms involved in the formation of 49-N-methyl piperazine CN adducts. The first approach was the use of 49-N-[ In the Mannich reaction, the secondary amine reacts with aldehyde to generate reactive iminium ions that can be trapped by electron-rich alkenes (Tanaka et al., 2008; Abonia et al., 2012) . Results from our study (Figs. 18 and 19) demonstrate that formaldehyde reacting with secondary alicyclic amines such as I and IX can generate 49-N-methyl piperazine CN adducts in the absence of HLM or NADPH, indicating this to be a direct Mannich reaction. Methanol can be an efficient one-carbon source as it has been shown to be readily oxidized to formaldehyde in microsomal incubations (Teschke et al., 1974) . We have shown in this study that formation of 49-N-methyl piperazine CN adducts from the secondary alicyclic amines (I, IX) in the HLM incubation with methanol and KCN required NADPH, demonstrating that methanol oxidation to formaldehyde was likely the first step of the one-carbon addition to those secondary alicyclic amines. Formaldehyde would appear to be a more efficient one-carbon donor. However, since the current CN-trapping study was qualitative with an excess amount of one-carbon donors in the microsomal incubations, formaldehyde and methanol generated similar amounts of 49-N-methyl piperazine CN adducts (Fig. 17) , and the kinetics of these reactions remain to be determined.
Compared with formaldehyde and methanol, CO 2 was less efficient as a one-carbon donor for the 49-N-methyl piperazine CN adduct formation (Fig. 17) . Primary and secondary amines have been reported to react with CO 2 to form carbamic acid in different in vitro and in vivo systems (Schaefer, 2006) . However, the mechanism of CO 2 incorporation into alicyclic secondary amine to form the reactive iminium ion remains to be further investigated. Our preliminary 13 C nuclear magnetic resonance analysis indicated that formation of carbamic acid was not detectable when compound I was directly reacted with [ 13 C]-labeled potassium carbonate in aqueous solution (unpublished data). Furthermore, our results demonstrated that this one-carbon addition to the alicyclic secondary amines (I and IX) was NADPH dependent, suggesting the involvement of cytochrome P450 enzyme catalyzed bioactivation. We hypothesized that when using potassium carbonate as the one-carbon source in the liver microsomal incubation, the carbamic acid formation would be the first step of this methylation, Iminium ions from piperazine a-carbon oxidation (pathway 1) have been considered a bioactivation process and those from pathway 2 as experimental artifact resulting from the potential interaction with formaldehyde in the incubation buffer (Gorrod and Sai, 1997; Li et al., 2006; Rousu and Tolonen, 2011; Barbara et al., 2012) . However, the biologic and toxicological implications of iminium ions via pathway 2 require further investigation for the following reasons. First, in the case of methanol and carbon dioxide, cytochrome P450 enzymes are likely involved in the one-carbon addition to the alicyclic secondary amines, resulting in piperazine N-methylene iminium ion formation. Second, the potential one-carbon donors can be found in vivo since carbon dioxide is abundant as carbonate anion in the body. Methanol occurs naturally in the human body as a product of metabolism and through intake of fruits, vegetables, and alcoholic beverages (Shelby et al., 2004; Turner et al., 2006) . Methanol levels in human blood range from 0.25 to 4.7 mg/l or 8 to 145 mM (Cook et al., 1991; Batterman and Franzblau, 1997) . The endogenous concentration of formaldehyde in the blood of rat, monkey, and human is about 100 mM, and the level in rat liver is 2-to 4-fold higher (Heck and Casanova, 2004) . The formaldehyde and methanol concentrations used in our study were 60 and 300 mM, respectively. Furthermore, the one-carbon addition products have been found in rat blood and urine dosed with homopiperazine (Martin et al., 2012) . These naturally abundant one-carbon sources could potentially fuel the bioactivation of secondary amines to form N-methylene iminium ions in vivo. The resulting reactive N-methylene iminium ions could potentially bind to macromolecules, which is a concern because of potential liability for mechanism-based inactivation or idiosyncratic toxicity. Therefore, pathway 2 is relevant to in vivo bioactivation and warrants further investigations of its association to adverse drug reactions. 
